Table 2. The limitations of approaches for the generation of beta-cells.
Ex-vivo generation of beta-cells | ESCs differentiation in vitro | iPSCs differentiation in vitro | Non-beta pancreatic cells transdifferentiation in vivo | Non-beta pancreatic cells transdifferentiation in vitro | Fibroblasts transdifferentiation in vitro | References | |
---|---|---|---|---|---|---|---|
Limited sources | Yes | Yes | No | Yes | Yes | No | Huang & Chang (2014) |
Risk of teratoma development | No | Yes | Yes | No | No | No | Hentze et al. (2009) |
Allograft rejection | No | Yes | No | No | No | No | Hentze et al. (2009) |
Lack of organization into islets | No | Yes | Yes | Yes | Yes | Yes | Zhou et al. (2008) |
Lack of reproducibility of the protocols | No | No | No | Yes | Yes | Yes | Kim, Jeong & Choi (2020) |
Off-target effects after manipulation with genome | No | No | Yes/Noa | Yes | Yes/Noa | Yes/Noa | Clayton et al. (2016) |
The necessity of deep invasion for cell product preparation | Yes | No | No | No | Yes | No | Trivedi et al. (2008) and Matsumoto & Shimoda (2020) |
The necessity of deep invasion for transplantation of final cell product | Yes | Yes | Yes | No | Yes | Yes | Shapiro, Pokrywczynska & Ricordi (2017) and Matsumoto & Shimoda (2020) |
Notes.
The presence of off-target effects will depend on the reprogramming methods (integrating or non-integrating).